To test this, we inoculated mice with KP.SIY tumors and used flow cytometry to assess the ability of SIY-specific CD8+ T cells to bind fluorescently labeled IL12-MSA ex vivo on day 7 of tumor growth. This evidence concerns the gene CD8A and neoplasm.